MedTrace Logo

Subconjunctival Injection of Local Anesthetic in Anterior Blepharoptosis Repair

NCT02959697 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-06-10

No results posted yet for this study

Summary

Blepharoptosis (ptosis) repair is a common and generally well tolerated surgical procedure usually performed using local anesthetic. However, a subset of patients appears to experience intraoperative pain/discomfort during ptosis repair using an anterior approach with subcutaneous local anesthetic. Posterior subconjuctival local anesthetic is currently used for eyelid procedures such as chalazion incision and drainage and full-thickness eyelid resections. The purpose of this study is to determine whether an additional subconjunctival injection of local anesthetic, through the posterior aspect of the eyelid, reduces intraoperative pain during anterior ptosis repair.

Conditions

  • Blepharoptosis
  • Ptosis

Interventions

DRUG

Subcut. + Subconj. Xylocaine

Patient will receive the standard subcutaneous local anesthetic as well as an additional subconjunctival injection of local anesthetic (Xylocaine).

DRUG

Subcut. + Sham Subconj. Injection

Patient will receive the standard subcutaneous local anesthetic as well as a subconjunctival sham injection of Normal Saline.

PROCEDURE

Blepharoptosis Repair

Patients will undergo blepharoptosis repair using an anterior approach.

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Matthew Lee-Wing, MD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2023-05-01
Completion
2023-06-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02959697 on ClinicalTrials.gov